Amneal Pharmaceuticals, Inc. AMRX Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $181.32M+459% | $127.93M+273% | $57.62M+139% | $51.24M+138% | $32.42M+127% | ||
| $33.51M+18.4% | $31.95M+15.1% | $30.96M+16.7% | $29.85M+14.3% | $28.3M+9.1% | ||
| $305.84M-0.4% | $339.99M+15.2% | $327.76M+4.8% | $351.08M+39.1% | $306.92M+44.2% | ||
| $65.08M+16.4% | $70.06M+34.9% | $63.45M+36.0% | $68.09M+64.7% | $55.89M+30.8% | ||
| -$116.18M-90.3% | -$112.26M-78.2% | -$82.87M-5.4% | -$81.12M-13.6% | -$61.03M+21.0% | ||
| $2.83B— | $2.69B— | $170M— | —— | —— | ||
| —— | —— | —— | -$234.4M+4.6% | -$227.8M-2.2% | ||
| $136.01M+711% | $194.52M+907% | $160.06M+1,027% | $34.05M— | $16.78M— | ||
| $240.77M-4.1% | $269.93M+11.0% | $264.31M-0.7% | $282.99M+34.0% | $251.03M+37.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Amneal Pharmaceuticals, Inc.'s cash flow data come from?
- Every line is extracted from Amneal Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.